跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,009 条关于
“CD-203c”
全部
2,009
临床试验
503
药物
881
机构
219
资讯
406
去年
Alys Pharmaceuticals Advances First-in-Class Mast Cell-Selective c-Kit Inhibitor ALY-301 to Clinical Trials for Cold Urticaria
去年
CD Biopharma's CD-001 Receives FDA Clearance for Phase 1 Trial in Oncology
去年
Sanofi Enters Talks with CD&R for $16.4B Consumer Health Unit Sale
9个月前
BioCorteX Partners with CD Biopharma to Accelerate Precision Immunotherapy Development Using AI-Driven Platform
去年
France Imposes Strict Conditions on Sanofi's €16 Billion Opella Healthcare Sale to CD&R
去年
Sanofi Completes €10 Billion Sale of Opella to CD&R, Transforms into Pure-Play Biopharma
去年
Abivax's Phase 2b Trial of Obefazimod for Crohn's Disease Enrolls First Patient
9个月前
ZYMFENTRA Shows Consistent Efficacy Across Crohn's Disease Locations in Post-Hoc Analysis of LIBERTY-CD Study
去年
Omvoh (mirikizumab) Shows Long-Term Efficacy in Ulcerative Colitis and Crohn's Disease
去年
Infliximab Maintains Efficacy in Crohn's Disease and Ulcerative Colitis Regardless of Immunosuppressant Use
第 1 页,共 41 页
上一页
下一页